Innventure Board Member Elizabeth Williams Granted $0 Cost Stock Awards

Rhea-AI Filing Summary

Director Elizabeth Suzanne Williams of Innventure received a grant of 22,305 Restricted Stock Units (RSUs) on June 25, 2025. Following this transaction, Williams now beneficially owns a total of 29,682 shares directly.

Key details of the RSU grant:

• Granted under the company's 2024 Equity and Incentive Compensation Plan
• Zero cost basis ($0 purchase price)
• Vesting occurs at the earlier of:
  • First anniversary of grant date
  • Next regularly scheduled annual stockholders meeting

The Form 4 was filed through an attorney-in-fact, Suzanne Niemeyer, on June 27, 2025. This equity award appears to be part of the company's director compensation program.

Insider Trade Summary

1 transaction reported

Mixed 1 txn

Insider Williams Elizabeth Suzanne

Role Director

Type	Security	Shares	Price	Value
Grant/Award	Common Stock	22,305	$0.00	--

Holdings After Transaction: Common Stock — 29,682 shares (Direct)

Footnotes (1)

1. [object Object]

Form 4 Insider Transactions: What Each Field Means →

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Williams Elizabeth Suzanne

(Last) (First) (Middle)

6900 TAVISTOCK LAKES BLVD, SUITE 400

(Street)

ORLANDO FL 32827

(City) (State) (Zip)

2. Issuer Name and Ticker or Trading Symbol
Innventure, Inc. [ INV ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
	Officer (give title below)		Other (specify below)

3. Date of Earliest Transaction (Month/Day/Year)
06/25/2025

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	06/25/2025		A		22,305(1)	A	$0	29,682	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

1. Restricted Stock Units ("RSUs") granted to the Reporting Person under the Innventure, Inc. 2024 Equity and Incentive Compensation Plan, and vesting on the earlier of (a) the first anniversary of the date of grant and (b) the next regularly scheduled annual meeting of stockholders of Innventure, Inc.

	/s/ Suzanne Niemeyer, Attorney-in-Fact	06/27/2025
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

How many shares of INV stock did Elizabeth Williams acquire on June 25, 2025?

Elizabeth Williams acquired 22,305 restricted stock units (RSUs) of INV common stock on June 25, 2025. Following this transaction, she beneficially owned a total of 29,682 shares directly.

What is the vesting schedule for Elizabeth Williams' INV RSU grant?

The RSUs will vest on the earlier of: (a) the first anniversary of the grant date (June 25, 2026) or (b) the next regularly scheduled annual meeting of stockholders of Innventure, Inc.

What was the purchase price of INV RSUs granted to Elizabeth Williams?

The RSUs were granted at $0 cost to Elizabeth Williams as part of her compensation under the Innventure, Inc. 2024 Equity and Incentive Compensation Plan.

What is Elizabeth Williams' role at INV?

Elizabeth Williams serves as a Director on the Board of Innventure, Inc. (INV), as indicated by the 'X' marked in the Director box on the Form 4 filing.

When was INV's Form 4 filing signed and by whom?

The Form 4 was signed by Suzanne Niemeyer as Attorney-in-Fact for Elizabeth Williams on June 27, 2025, one day before the filing date of June 28, 2025.